MannKind | MNKD - Current Liabilities

Stock Price
2.77
Daily Change
-0.05 -1.77%
Monthly
-50.00%
Yearly
-46.73%
Q1 Forecast
2.69

MannKind reported $171.03M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Adma Biologics USD 56.49M 18.45M Sep/2025
BioCryst Pharmaceuticals USD 190.24M 13.08M Sep/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Halozyme Therapeutics USD 177.09M 660.14M Dec/2025
Insmed USD 468.87M 51.66M Dec/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
MannKind USD 171.03M 61.9M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Minerva Neurosciences USD 2.29M 381K Dec/2025
Novavax USD 429.87M 40.73M Sep/2025
Novo Nordisk DKK 32.79B 203.33B Jun/2025
Pfizer USD 36.6B 1.13B Sep/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Xencor USD 95.91M 9.42M Dec/2025